BioGaia
BioGaia is a Swedish healthcare company specializing in the development, marketing, and sale of probiotic products. The company operates through three main segments: the Paediatrics segment, which offers probiotic drops, gut health tablets, oral rehydration solutions, and cultures for use in licensed infant formula; the Adult Health segment, which includes gut health tablets, oral health lozenges, and cultures for licensed dairy products; and an Other segment that generates royalties from development projects and revenue from packaging solutions through its subsidiary CapAble. BioGaia's products aim to improve health across various demographics, with a strong focus on both pediatric and adult consumers. The company operates in multiple regions, enhancing its global presence in the probiotic market.
3 past transactions
Boneprox
Seed Round in 2021
Boneprox is a dental health technology company that develops software for dental imaging, diagnostics and workflow optimization. Its platform includes Boneprox, a tool to analyze bone quality and osteoporosis risk; ReferralExpress, a tool to streamline referrals to specialists; and CBCT-Supervision, designed to simplify cone-beam CT workflows in clinics. By leveraging advanced dental imaging, digital dentistry and artificial intelligence, Boneprox enables secure exchange, analysis and interpretation of patient images, helps clinics identify at-risk patients from standard dental X-rays, and supports efficient sending, receiving and diagnosing of images, contributing to greater access to dental specialists.
MetaboGen
Acquisition in 2018
MetaboGen is a research and development company focused on biomarker and personalized treatment services. It specializes in integrating metagenomic data analysis with clinical programs, aiming to develop innovative therapeutics and next-generation probiotics. The company identifies and enhances bacterial strains related to specific indications, which supports the probiotic industry in creating novel diagnostic tests and treatments. Through its expertise in metagenomics, MetaboGen contributes to advancements in personalized medicine and the development of effective probiotic solutions.
MetaboGen
Corporate Round in 2018
MetaboGen is a research and development company focused on biomarker and personalized treatment services. It specializes in integrating metagenomic data analysis with clinical programs, aiming to develop innovative therapeutics and next-generation probiotics. The company identifies and enhances bacterial strains related to specific indications, which supports the probiotic industry in creating novel diagnostic tests and treatments. Through its expertise in metagenomics, MetaboGen contributes to advancements in personalized medicine and the development of effective probiotic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.